Dr. Felker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4401 Penn Ave
Pittsburgh, PA 15224Phone+1 412-692-8864- Is this information wrong?
Summary
- Dr. James Felker is a pediatric hematologist/oncologist in Pittsburgh, PA and is affiliated with UPMC Children’s Hospital of Pittsburgh. He received his medical degree from New York Medical College and has been in practice 7 years. He specializes in pediatric hematologic oncology and pediatric neuro-oncology and is experienced in pediatric brain tumors, pediatric spinal tumors, pediatric coagulation disorders, pediatric neuro-oncology, and pediatric solid tumor oncology.
Education & Training
- Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2014 - 2017
- McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2010 - 2013
- New York Medical CollegeClass of 2010
- Cornell UniversityBS, 2002 - 2006
Certifications & Licensure
- PA State Medical License 2018 - 2024
- GA State Medical License 2014 - 2020
- IL State Medical License 2010 - 2014
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha
- 1st Place Department of Pediatrics Research Competition Emory University Department of Pediatrics, 2017
- 2nd Place Basic Science Poster Southeastern Pediatric Research Innovation Conference, 2016
Clinical Trials
- A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma Start of enrollment: 2022 Jul 01
Roles: Contact
- A Vaccine Trial for Low Grade Gliomas Start of enrollment: 2015 Jan 01
- Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma.Plute, T., Felker, J. T., Stephanie M Casillo, Taylor A Gatesman, Akanksha Chilukuri, Srinidhi Varadharajan, Brenden J Johnson, Daniel R David Premkumar, Esther P Jane...> ;Cell Reports. 2024 Jan 23
- 1 citationsHurdling over the blood-brain barrier with exosome technology.James Felker, Sameer Agnihotri> ;Neuro-Oncology. 2022 Nov 2
- 1 citationsAuthor Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome.Rich, J., Brian J Golbourn, Matthew E Halbert, Katharine Halligan, Srinidhi Varadharajan, Brian Krug, Nneka E Mbah, Nisha Kabir, Ann-Catherine J Stanton, Abigail L Loc...> ;Nature Cancer. 2022 Jul 1
- Join now to see all
Abstracts/Posters
- Organotypic Tumor Slice Culture for Evaluating Treatment of MedulloblastomaFelker J, Dey A, MacDonald T, Kenney, A, Oral Presentation at the 21st Annual Scientific Meeting of the Society For Neuro-Oncology, Scottsdale, AZ, 11/1/2016
- Organotypic Slice Culture for Evaluating Treatment of MedulloblastomaFelker J, Dey A, Metrock K, Liu J, MacDonald T, Kenney, A, Presented at the Molecules for Minions: Southeastern Pediatric Research Innovation Conference, Atlanta, GA, 6/22/2016
Press Mentions
- CURE Childhood Cancer Funds Two Pediatric Oncology Fellowships: Meet Dr. Ryan Summers and Dr. Jim FelkerMay 3rd, 2017
Grant Support
- Sam Robb FellowCURE Childhood Cancer FoundationPresent
Professional Memberships
- Member
- Fellow
- Member
- The American Society of Pediatric Hematology/OncologyMember
- Society for Neuro-OncologyMember
Hospital Affiliations
- UPMC Children's Hospital of PittsburghPittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: